Acute myocardial infarction is diagnosed in approximately 1.5 million emergency department visits per year in the United States, and emergency medicine physicians miss or initially misdiagnose a meaningful percentage of them. Patients who present with atypical symptoms (absent chest pain, presentation dominated by dyspnea, nausea, jaw pain, or fatigue) are at the highest risk of missed diagnosis, as are women and diabetic patients whose AMI presentations frequently diverge from the classic anterior chest pain picture taught in medical school. When a missed diagnosis allows infarction to progress over hours, the resulting myocardial damage can produce permanent reduced ejection fraction, dysrhythmia, congestive heart failure, and death from extension of the infarct into previously viable tissue.
The Standard of Care: STEMI Versus NSTEMI Workup
Emergency medicine has bifurcated the acute coronary syndrome workup into two diagnostic pathways with separate standard-of-care benchmarks.
ST-elevation myocardial infarction (STEMI) requires a 12-lead ECG within 10 minutes of patient presentation for any patient with chest pain, shortness of breath, or other ACS-consistent symptoms. The STEMI diagnosis is made on the initial ECG when ST-segment elevation is present in two or more contiguous leads meeting the applicable amplitude criteria. The standard of care for confirmed STEMI requires activation of the catheterization lab within a defined door-to-balloon time: the American College of Cardiology and American Heart Association guidelines target 90 minutes from first medical contact to balloon inflation for primary PCI. Many hospitals track and publicly report their door-to-balloon times as a quality metric. A patient who presented with symptoms consistent with ACS and whose STEMI was identifiable on an ECG that was either not obtained within the required window or was misread by the treating provider has a straightforward standard-of-care violation as the liability foundation.
Non-ST-elevation myocardial infarction (NSTEMI) and unstable angina are diagnosed through the combination of clinical presentation, ECG findings (which may show ST depression, T-wave changes, or no acute changes), and cardiac biomarker testing. The current standard requires high-sensitivity troponin (hs-cTn) at presentation and again at one or three hours, depending on the assay type and the protocol the hospital has adopted. Patients with rising troponin values between draws, even without ECG changes, meet the biomarker criteria for AMI and require cardiology consultation and invasive evaluation. A patient whose serial troponin values showed a rising pattern consistent with NSTEMI but who was discharged without cardiology consultation or admitted to a non-monitored bed has a care process failure as the malpractice predicate.
Atypical Presentation and the High-Risk Population
The most frequently litigated failure-to-diagnose cardiac cases involve patients whose presentation was atypical. The patient complaint-driven reasoning that drives many emergency department workups creates a systematic vulnerability: if the presenting complaint is documented as epigastric pain, back pain, or generalized weakness rather than chest pain, the ACS workup may not be initiated unless the provider independently recognizes the possibility of a cardiac etiology. The standard of care requires ECG and troponin evaluation for any patient in a high-risk demographic presenting with symptoms that could represent an ACS equivalent, regardless of whether the patient's subjective complaint is framed as cardiac.
High-risk populations for atypical presentation include:
- Women, who more frequently present with dyspnea, fatigue, nausea, and vomiting as primary symptoms
- Diabetic patients, in whom autonomic neuropathy can blunt ischemic chest pain (silent MI)
- Elderly patients, who may present with syncope, confusion, or generalized weakness
- Patients with a recent cocaine or stimulant use history, who can present with vasospasm-mediated ACS at younger ages
Emergency medicine expert testimony in these cases focuses on whether the provider's workup decision for a patient in a high-risk demographic was consistent with the standard of care, not merely whether the provider responded appropriately to the patient's self-report. A 58-year-old woman with diabetes presenting to the ED with fatigue and nausea who does not receive an ECG in the first 10 minutes has received below-standard care regardless of whether she described her symptoms as cardiac.
Causation: Quantifying the Myocardial Damage From the Delay
Causation in a cardiac misdiagnosis case requires expert testimony that the delay in diagnosis and treatment resulted in additional myocardial injury beyond what would have occurred with timely intervention. This is a quantifiable medical opinion: time-to-reperfusion studies in STEMI cases establish a well-characterized relationship between door-to-balloon time and final infarct size. Myocardium at risk (the zone of potentially salvageable cardiac muscle in the area supplied by the occluded artery) is lost progressively during the ischemic period, and the amount of loss per hour is estimable from published cardiology literature.
The causation expert in a cardiac malpractice case should be prepared to testify to:
- The time of the plaintiff's actual presentation and the time at which the diagnosis was or should have been made
- The additional time during which myocardial ischemia progressed as a result of the missed diagnosis
- The estimated area of additional myocardium lost during that window based on the patient's angiographic findings and published time-to-loss data for the specific culprit vessel
- The ejection fraction reduction or functional impairment attributable to the additional infarct area
- The causal relationship between the additional infarct and the plaintiff's specific permanent impairment, dysrhythmia, or mortality risk elevation
Post-event cardiac imaging (cardiac MRI with gadolinium late enhancement, or echocardiography with wall motion analysis) provides objective evidence of final infarct size that the expert uses to work backward to the counterfactual: what size would the infarct have been with timely intervention. In cases where the patient died, autopsy findings and post-mortem cardiac pathology provide the equivalent data.
Hospital System Defendants and Quality Metric Evidence
In many cardiac misdiagnosis cases, the hospital system is an appropriate defendant alongside the treating emergency medicine physician. Hospitals that have adopted ACS protocols inconsistent with ACC/AHA guidelines, that have inadequate staffing for timely ECG performance, or that lack high-sensitivity troponin assay availability have system-level care failures that contribute to individual-level misdiagnosis. Hospital quality data on door-to-balloon times, STEMI protocol activation rates, and ACS care bundle compliance are discoverable and may support a negligent credentialing or negligent systems-level claim.
For medical malpractice resources including causation expert strategy and standard of care analysis, see medical malpractice practice resources. For wrongful death damages frameworks in cardiac fatality cases, see wrongful-death practice resources.